Truist Financial Lowers Aveanna Healthcare (NASDAQ:AVAH) Price Target to $9.00

Aveanna Healthcare (NASDAQ:AVAH) had its price target lowered by investment analysts at Truist Financial from $10.00 to $9.00 in a research note issued on Friday,Benzinga reports. The firm presently has a “hold” rating on the stock. Truist Financial’s target price suggests a potential upside of 36.05% from the stock’s current price.

Several other research analysts have also issued reports on the company. UBS Group increased their price objective on Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “neutral” rating in a research note on Thursday, January 15th. William Blair assumed coverage on shares of Aveanna Healthcare in a report on Monday, December 8th. They set an “outperform” rating for the company. Raymond James Financial raised shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price objective on the stock in a research note on Friday. Weiss Ratings reissued a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Monday, December 29th. Finally, Royal Bank Of Canada raised their price target on Aveanna Healthcare from $10.00 to $11.00 and gave the company a “sector perform” rating in a report on Thursday, January 15th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $10.94.

Aveanna Healthcare Price Performance

NASDAQ AVAH traded up $0.28 on Friday, reaching $6.62. The company’s stock had a trading volume of 733,519 shares, compared to its average volume of 1,193,720. The firm has a market cap of $1.38 billion, a PE ratio of 18.34 and a beta of 2.07. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 140.39. Aveanna Healthcare has a 52 week low of $3.73 and a 52 week high of $10.32. The business has a 50-day moving average price of $7.88 and a 200 day moving average price of $8.50.

Insider Activity

In other news, CFO Matthew Buckhalter sold 13,512 shares of the business’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $7.21, for a total transaction of $97,421.52. Following the completion of the transaction, the chief financial officer directly owned 529,243 shares in the company, valued at approximately $3,815,842.03. The trade was a 2.49% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Edwin C. Reisz sold 60,769 shares of the stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total transaction of $438,144.49. Following the completion of the sale, the insider owned 1,447,057 shares in the company, valued at $10,433,280.97. This represents a 4.03% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 998,595 shares of company stock worth $7,567,770. Corporate insiders own 7.80% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. AustralianSuper Pty Ltd acquired a new stake in Aveanna Healthcare in the 3rd quarter valued at $15,743,000. Vanguard Group Inc. raised its stake in shares of Aveanna Healthcare by 38.0% during the 4th quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock worth $45,564,000 after purchasing an additional 1,535,351 shares in the last quarter. Millennium Management LLC grew its stake in shares of Aveanna Healthcare by 1,007.1% in the fourth quarter. Millennium Management LLC now owns 1,114,717 shares of the company’s stock valued at $9,107,000 after buying an additional 1,014,030 shares in the last quarter. Nuveen LLC increased its holdings in Aveanna Healthcare by 135.9% during the fourth quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock worth $12,838,000 after buying an additional 905,316 shares during the last quarter. Finally, Hillsdale Investment Management Inc. bought a new stake in Aveanna Healthcare during the third quarter worth $7,922,000. 87.96% of the stock is currently owned by institutional investors.

More Aveanna Healthcare News

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Q4 results materially beat estimates — Aveanna reported revenue of $662.5M (up ~27% YoY) and an EPS beat (reported $0.83 vs. consensus near $0.13). The strong top‑line growth and big EPS beat are the main bullish catalysts. GlobeNewswire Q4 Results
• Positive Sentiment: Raymond James upgraded AVAH from Outperform to Strong‑Buy and set a $13 price target (~~97% above the recent price), which likely boosted investor demand and sentiment. Finviz (Raymond James Upgrade)
• Neutral Sentiment: Earnings call / transcripts available for detail — Investors can review management’s commentary on margins, organic growth and reimbursement trends in the Q4 call transcript to assess sustainability of recent results. Earnings Call Transcript
• Neutral Sentiment: Short‑interest data in recent reports appears unreliable/zeroed out (reported as 0 shares), so it doesn’t provide a clear signal on positioning or potential squeezes at the moment.
• Negative Sentiment: Fiscal‑2026 revenue/growth outlook disappointed some analysts and investors — coverage noted that the company’s revenue outlook trailed consensus, which pressured the stock despite the Q4 beat. That guidance miss is the main bearish offset to today’s gains. MSN (Guidance Miss)
• Negative Sentiment: Some outlets flagged the fiscal‑2026 guidance update as a reason for intracday weakness after the initial pop, highlighting that near‑term growth assumptions and reimbursement dynamics will be key watchpoints for investors. TipRanks (Guidance & Outlook)

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.